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Quantification of Inducible SOS-Like Photoprotective
Responses in Human Skin
Simin Arad1, Nellie Konnikov1, David A. Goukassian1 and Barbara A. Gilchrest1
To document and quantify inducible photoprotective effects in human skin, explant cultures were treated once
with thymidine dinucleotide (pTT) or diluent alone or UV-irradiated. Both pTT and UV increased the
melanogenic protein levels on days 1–5 and comparably increased melanocyte dendricity and epidermal
melanin content. Explants treated with pTT or UV but not with diluent alone showed initial inhibition of
epidermal proliferation followed by mild reactive hyperplasia; melanocyte proliferation was minimal. To
determine whether pTT and UV provide comparable protection against subsequent UV-induced DNA damage,
explants were pTT- or diluent-treated or UV-irradiated. All explants were then irradiated with the same UV dose
72 hours later. Compared to diluent alone, pTT or UV pretreatment decreased the number of epidermal cells
positive for cyclobutane pyrimidine dimers (CPDs) 50% immediately post-irradiation. In pTT- and UV- versus
diluent-pretreated explants, the rate of CPD removal was also more rapid, approximately 80 vs 45% of the initial
burden within 72 hours. These data confirm and quantify comparable SOS-like responses in human skin after
pTT or UV irradiation, attributable to both increased epidermal melanin and increased DNA repair rate, in the
case of pTT in the absence of initial damage.
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INTRODUCTION
It is well established that UV exposure is the leading cause of
skin cancer worldwide (Woodhead et al., 1999). One of the
best known protectors against damaging effects of UV in the
mammalian skin is melanin (Kollias et al., 1991; Tadokoro
et al., 2003). Melanin serves as neutral density filter,
absorbing photons across the entire spectrum of UV and
visible light, and also scavenges reactive oxygen species
produced during UV exposure (Agar and Young, 2005).
Melanin content largely determines the sensitivity of cells to
irradiation, and melanocytes with high melanin content are
more resistant to cytotoxic effects of UV (Kobayashi et al.,
1993; Smit et al., 2001). Additionally, dark skinned people
are at lesser risk to both acute and chronic photodamage,
including skin cancer (Sheehan et al., 2002; Rijken et al.,
2004).
Human skin has two well-recognized inducible defense
mechanisms against damaging effects of UV exposure:
thickening of the viable epidermis and stratum corneum
and increased epidermal melanin content. ‘‘Tanning’’ or
enhanced melanogenesis is considered the main defense
mechanism in all but skin type I individuals, who by
definition easily burn and never tan (Fitzpatrick, 1988). In
other skin types, acute sun exposure induces tanning that is
clinically apparent after 3–5 days (Pathak and Fanselow,
1983) and persists up to several weeks after irradiation,
depending on UV irradiation dose and skin phototype.
This increased pigmentation, often distributed in supra-
nuclear caps (Kobayashi et al., 1998), is understood to
protect against subsequent UV damage to DNA and
other cellular components (Pathak and Fanselow, 1983;
Kadekaro et al., 2003). Although the exact mechanisms of
tanning are complex, increased levels of melanogenic
proteins, specifically the rate-limiting enzyme tyrosinase
(Tyr), and enhanced melanocyte dendricity are major
contributors (Gilchrest et al., 1996; Gilchrest and Eller,
1999). We have previously shown that DNA damage or its
repair induces melanogenesis (Eller et al., 1996), and we
(Khlgatian et al., 2002) and others (Nylander et al., 2000)
have found that Tyr, the rate-limiting enzyme in melanogene-
sis (Hearing and Jimenez, 1989), is p53 regulated, consistent
with the role of tanning as a protective DNA damage
response (Gilchrest, 2004).
Cyclobutane pyrimidine dimers (CPDs), the major DNA
photoproducts generated during UV exposure (Freeman
et al., 1989; Vink and Roza, 2001), are removed by
nucleotide excision repair progressively over several days
(Sancar, 1994; Young et al., 1996). The individual’s
constitutive rate of CPD removal following UV irradiation,
determined using cultured peripheral blood lymphocytes and
dermal fibroblasts, has been shown to correlate inversely
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with risk of skin cancer development and mutagenesis rate
(Wei et al., 1993; Moriwaki et al., 1996). DNA damage
causes cell cycle arrest, a period during which damage may
be repaired with consequence, but CPDs not removed before
the resumption of DNA replication may cause mutations and
eventually skin cancer (Brash et al., 1991; Courdavault et al.,
2005). It has been shown that fair skin contains more CPDs
than dark skin after a single UV exposure (Strickland et al.,
1988; Bykov et al., 2000) and accumulates a greater burden
of CPDs after multiple exposures (Young et al., 1996),
accounting, at least in part, for the increased susceptibility
of fair skin to photocarcinogenesis (Parkin and Muir, 1992;
van Nieuwpoort et al., 2004).
We have previously shown that thymidine dinucleotide
(pTT), the obligate substrate for UV-induced thymine dimers,
stimulates melanogenesis in cultured human melanocytes,
guinea-pig skin, and human skin explants (Eller et al., 1994,
1996; Gilchrest and Eller, 1999, Arad et al., 2006),
presumably by activating the same DNA damage response
pathways as activated by UV irradiation (Gilchrest and Eller,
2005). In bacteria, UV-damaged DNA stimulates the
so-called SOS response (Radman, 1975) that consists of the
de-repression of multiple genes encoding DNA repair
proteins, leading to more rapid DNA repair and enhanced
bacterial survival (Bjedov et al., 2003; Matic et al., 2004). In
cultured human cells, pTT similarly upregulates DNA repair
enzymes and enhances the rate of repair of DNA damage
(Eller et al., 1997; Goukassian et al., 2002). Furthermore, in a
murine model of photocarcinogenesis, intermittent topical
treatment with pTT reduces mutation rate and delays and
reduces skin cancer development (Goukassian et al., 2004).
The ability of pTT to evoke tanning and other protective
responses appears to be based on its partial homology to the
telomere repeat sequence TTAGGG (Ohashi et al., 2007).
Telomere homolog oligonucleotides rapidly enter the nucleus
(Hadshiew et al., 2001; Eller et al., 2002) and are postulated
to mimic a physiologic DNA damage signal, exposure of the
telomere 30 overhang (Eller et al., 2003; Li et al., 2003),
leading to interaction with the telomere-associated WRN
protein (Eller et al., 2006), whose mutation causes the
progeroid cancer-prone disorder, Werner syndrome (Kyng
and Bohr, 2005).
In this study, we have expanded our previous work with
human skin explants to quantify the photoprotective SOS-like
responses that are induced by UV irradiation, specifically by
the consequent DNA damage, or by telomere homolog
oligonucleotides without the requirement for initial DNA
damage. Paired human skin explants were treated with pTT
or diluent alone or UV-irradiated to quantify melanogenic
responses; and then explants in all initial treatment groups
were UV irradiated and studied over an additional 72 hours
to document the anticipated SOS-like responses. The
observed reduction in initial DNA damage combined with
accelerated removal of UV-induced photoproducts docu-
ment enhanced ability of previously UV-irradiated or pTT-
treated human skin to preserve genomic integrity. That pTT,
unlike UVB, induces protective responses without the
requirement for initial DNA damage suggests a novel means
of reducing mutagenesis and decreasing the carcinogenic risk
in sun-exposed human skin.
RESULTS
pTT treatment and UV exposure comparably induce tanning
In skin explant sections from three different donors (aged
57710 years, mean7SD) double immunostaining with Tyr
and tyrosinase-related protein 1 (TRP-1 or Mel5) revealed a
significant (2- to 3-fold) increase in the number of positive
cells in both pTT-treated and UV-irradiated skin, compared to
diluent-treated skin (Figure 1a, upper panel). Virtually all
cells positive for one of the melanocyte markers were positive
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Figure 1. Human skin explants from three donors/treatment group were
supplemented with diluent, pTT (100 lM) or irradiated with 30 mJ/cm2 of
UVB. (a) Images from the 72 hours time point are shown. pTT treatment and
UV irradiation increase the number of detectable melanocytes and increase
pigmentation in human skin. (Upper panel) Diluent-treated skin showed
constant low Tyr/Mel5 expression over the 120 hours experiment (Figure
S1a–c). Comparable to UVB irradiated skin, pTT treatment upregulated the
number of Tyr/Mel5 double (þ ) cells (yellow-reddish) within 24 hours and
this upregulation persisted through 120 hours (Figure S1a–c). Here and
elsewhere the dermoepidermal junction is indicated by the dashed line;
original magnification 400, all panels. (Lower panel) Representative images
of Fontana Masson staining of the adjacent sections shown in (a) (upper panel)
reveal increased melanin content and nuclear ‘‘capping’’ in pTT-treated as
well as in UV-irradiated skin after 72 hours. No change in melanin content
was evident in diluent-treated control skin. Low power images of the same
cross-sections are shown in Figure S3. (b) pTT treatment and UV exposure
increase dendricity of melanocytes. Representative confocal images of Tyr
(green)/Mel5 (red) double (þ ) cells (yellow) revealed increased dendricity
of melanocytes after 72 hours in pTT-treated as well as UV-irradiated skin.
No changes were detectable in control diluent-treated explants; original
magnification  1,200, all panels.
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for both at all time points within 24 hours and through 5 days
(Figure S1a–c), consistent with similar rates of induction for
the two melanogenic proteins in these minimally proliferative
cells (Figure S2a–e). Fontana Masson staining revealed
increased melanin content with nuclear cap formation in
both pTT-treated and UV-irradiated skin (Figure 1a, lower
panel) as early as 24 hours after treatment that progressed
through 5 days (Figure S3). No change in melanin content
was evident in diluent-treated skin explants over the 5-day
period (Figure S3). By confocal microscopy, increased
dendricity was apparent in pTT-treated and UV-irradiated
skin within 72 hours (Figure 1b), persistent through day 5,
whereas in diluent-treated skin there was no detectable
change.
pTT treatment and UV exposure modulate epidermal
proliferation, and minimally affect melanocyte proliferation
To evaluate effects of these treatments on keratinocyte and
melanocyte proliferation, adjacent sections were processed
for double immunostaining with Tyr (green, melanocyte
marker) and Ki67 (red, proliferation marker). Control non-
treated unirradiated explants (time 0) had low levels of Ki67
(þ ) cells, presumably keratinocytes, as they did not stain for
Tyr (Figure 2a, upper panel). The number of Ki67 (þ ) cells
and Tyr (þ ) cells in diluent-treated unirradiated explants
remained unchanged over 5-day experiment (Figure 2a–c and
Figure S2a–e). After 24 hours, the number of Ki67 (þ ) cells
was less than 50% of the diluent controls in both pTT-treated
and UV-irradiated explants, consistent with the expected
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Figure 2. Adjacent sections of the same explants shown in (Figure 1a and b) were reacted with Tyr, to identify melanocytes, and with Ki67, to identify
proliferating cells. (a) Tyr/Ki67 double staining shows increase in Tyr (þ ) cells (green) in pTT-treated and UV-irradiated skin samples over 5-day experiment.
No change in the low number of Tyr (þ ) cells was detectable in control non-treated unirradiated and diluent-treated skin. Compared to control diluent-treated
skin, the number of Ki67 (þ ) cells (red) was increased in pTT-treated and UV-irradiated skin 48–120 hours after treatments. Interestingly, very few double
Tyr/Ki67 (þ ) cells (yellow) were detectable in pTT-treated and UV-irradiated skin sections 96 and 120 hours after treatments; original magnification 400, all
panels. (b) Quantitative analysis of Tyr (þ ) cells as determined by blindly examining at least 3–5 fields ( 400) and averaging. Values are expressed per 100 mm
of epidermal length and represent explants prepared from three donors. Compared to diluent-treated skin, the number of Tyr (þ ) cells were doubled by 24 hours
in pTT- and UVB-treated skin samples (1.570.7 vs 4.170.7 and 4.270.9, diluent vs pTT and UVB, Po0.001; P¼NS pTT vs UVB) and tripled by 48 through
120 hours (1.970.2 vs 5.270.6 and 5.970.5, diluent vs pTT and UVB, Po0.001; P¼NS pTT vs UVB). Here and elsewhere: D¼ diluent, T¼pTT, U¼UVB.
(c) Quantitative analysis of Ki67 (þ ) cells was performed as described above for (b). Compared to diluent-treated skin, Ki67 (þ ) cells were decreased initially
in pTT- and UVB-treated skin by 24 hours (3.570.5 vs 1.670.4 and 1.270.3, diluent vs pTT and UVB, Po0.01; P¼NS pTT vs UVB), and were significantly
increased by 48 through 120 hours (2.170.3 vs 3.570.6 and 4.570.8, diluent vs pTT and UVB, Po0.02 diluent vs pTT; Po0.0003 diluent vs UVB; P¼NS
pTT vs UVB). (d) Quantitative analysis of double Tyr/Ki67 (þ ) cells was performed as described above for (b and c). There was very few (below 1/100 mm
of epidermal length) double Tyr/Ki67 (þ ) cells after any of the treatments over 120-hours experiment, indicating that neither pTT nor UVB had an effect
on melanocyte proliferation.
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transient cell cycle arrest caused by both treatments (Eller
et al., 1997; Decraene et al., 2005), then increased by
approximately 50–100% compared to the diluent controls at
the same time points at 48 through 120 hours (Figure 2a and
c, and Figure S2a–e), consistent with the well-described
‘‘rebound hyperproliferation’’ observed after UV-induced
epidermal growth arrest (Lee et al., 2002). In pTT-treated
and UV-irradiated explants, Tyr (þ ) cells doubled in number
within 24 hours and further to 2–3 times the diluent control
levels over the 5 post-treatment days, as noted above (Figure
2a and b, and Figure S2a–e). However, very few Tyr/Ki67 (þ )
cells, representing proliferating melanocytes, were detected
after pTT treatment or UV exposure (Figure 2a and d and
Figure S2a–e), none in the pTT-treated explants until 72 hours,
indicating that the increased number of detectable melano-
cytes was due to higher levels of melanogenic proteins per
cell and not to increased cell number.
UV or pTT pretreatment protects against subsequent
UV-induced DNA damage and enhances DNA repair rate
To evaluate and compare the inducible photoprotection
afforded by pTT treatment and UV irradiation against
subsequent irradiation in human skin, we evaluated DNA
damage and repair in skin explants using CPD immunostain-
ing. At baseline, 72 hours after pTT or diluent treatment or
after an initial UV irradiation (1st UVB), CPDs were present
only in irradiated explants, as expected (Figure 3a). Im-
mediately after irradiation (0 hour, 2nd UVB), there were
more CPD (þ ) cells visible in diluent-pretreated skin than in
pTT-pretreated or UV-preirradiated sections (Figure 3b, upper
panel), consistent with their greater melanin content (Figure
1a, lower panel and Figure S3) and consequent absorption of
photons otherwise available to produce dimers. In diluent-
treated skin sections, CPD (þ ) cells were evenly distributed
throughout the entire epidermis, including basal layer,
whereas in pTT and UVB sections pretreated for 72 hours,
CPDs were detected in upper layers of epidermis and almost
completely spared basal and immediate suprabasal layers
(Figure 3b, upper panel), suggesting preferential melanin
protection of the proliferative compartment containing Ki67
(þ ) cells (Figure 2a, red-stained cells and Figure S2a–e), as
previously reported after UVB irradiation (Yamaguchi et al.,
2006).
In eight different Caucasian donors (57710 years old,
mean7SD), compared to diluent-pretreated explants, there
was an average decrease of approximately 50% in the
number of CPD (þ ) cells immediately after UV irradiation in
both pTT-pretreated and UV-preirradiated skin (diluent
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Figure 3. We examined the removal of UV-induced CPDs by immunohistology using CPD-specific antibodies. At time 0, skin explants were pTT- and
diluent treated or UV irradiated as described in Material and Methods. (a) Green-nuclear staining indicates CPD (þ ) nuclei and the dermoepidermal junction
are delineated as above. As expected, no CPDs were detected in diluent- and pTT-treated skin samples 72 hours after either treatment (as well as at time 0 –data
not shown), whereas significant number of CPDs were detected in UVB-irradiated skin explants (72 hours 1st UVB). (b) Seventy-two hours after diluent and
pTT treatment and UVB irradiation (1st UVB), all skin samples were UV-irradiated with 30 mJ/cm2 UVB and harvested immediately (upper panel) and 72 hours
after 2nd UVB (lower panel). Diluent-treated skin revealed significantly higher number of CPD (þ ) cells immediately after 2nd UVB in contrast to pTT-treated
or UV-irradiated skin. There were fewer CPD (þ ) cells detectable 72 hours after 2nd UVB exposure in UV-preirradiated and in pTT-pretreated skin. Please
note, that in diluent-pretreated skin samples CPDs were evenly distributed throughout the entire epidermis. In contrast, in pTT-pretreated skin samples CPDs
were predominantly distributed in the granular layer and in UVB-pretreated samples most of the CPDs were also in the granular layer and a few were also
detected in suprabasal layer. No CPD (þ ) nuclei were detectable in the basal layer of pTT-pretreated or UVB-preirradiated skin samples. (c) pTT protects
human skin from initial photodamage. Quantification of CPD (þ ) nuclei in UV-irradiated human skin explants. All samples were coded, and then evaluated
by a single blinded observer to eliminate bias and interobserver variability. CPD burden was defined as ratio of intensity for CPD staining vs DAPI nuclear
staining (see Materials and Methods) in at least 8–10 randomly selected areas of 100 mm of epidermal length in skin explants from eight donors for each
treatment condition/time point. Quantification of the initial CPDs after 72 hours is shown for diluent-treated (clear bars), pTT-treated (gray bars), and
UVB-irradiated (black bars) epidermis (Po0.001 diluent vs pTT and UVB). (d) Quantification of CPD (þ ) cells 72 hours after 2nd UVB was performed as
described above for (c). Results are expressed as the percent of initial CPD burden (set at 100% and defined as ratio of intensity for CPD staining vs DAPI
nuclear staining) after 72 hours for each treatment condition.
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0.670.04 vs pTT 0.2670.07 vs UV 0.3470.02, Po0.0002
for diluent vs both pTT and UVB, P¼NS (nonsignificant) for
pTT vs UVB) (Figure 3b (upper panel) and c).
Following the second UV exposure, previously unirra-
diated diluent-treated control explants showed a 47.174.9%
reduction in CPD (þ ) cells after 3 days, whereas pTT-
pretreated or UV-preirradiated explants showed 77.470.7
and 7476.1% reductions, respectively (Po0.001, diluent vs
pTT and diluent vs UVB, respectively), a highly significant
acceleration of repair (Figure 3b (lower panel) and d).
DISCUSSION
Melanogenesis is the major recognized defense mechanism
in human skin against acute and chronic UV irradiation
(McGregor and Hawk, 1999; Sheehan et al., 2002). Melanin
is synthesized in melanosomes and transferred via dendrites
to neighboring keratinocytes, forming supranuclear caps that
protect the nucleus against incidental UV irradiation, and
both melanin synthesis and dispersion increase after UV
exposure (Mitchell et al., 2001). The UV action spectrum for
tanning is the same as for DNA photoproduct induction
(Parrish et al., 1982; Freeman et al., 1989), suggesting the
subsequently established cause and effect relationship
between DNA damage and melanogenesis (Eller et al., 1996).
UV exposure upregulates Tyr, the rate-limiting enzyme in
melanogenesis (Hearing and Jimenez, 1989). Tyr and TRP-1
are upregulated by p53 (Nylander et al., 2000; Khlgatian
et al., 2002), a transcription factor known to be activated by
pTT as well as by UV irradiation (Eller et al., 1997; Marwaha
et al., 2005; Arad et al., 2006). Our group and others have
shown that pTT treatment increases Tyr mRNA and protein
levels in cultured melanocytes and S91 mouse melanoma
cells (Eller et al., 1996; Pedeux et al., 1998; Eller and
Gilchrest, 2000). In addition, it has been previously reported
that Tyr and TRP-1 levels can double in human skin 24 hours
after a single UVB exposure (Kim et al., 2003; Tadokoro
et al., 2005). In this study, immunostaining for Tyr and TRP-1
revealed a doubling of detectable melanocytes within
24 hours and tripling over 5 days after pTT treatment or
UVB irradiation, confirming earlier studies (Arad et al., 2006).
Over the years, several mechanisms, not mutually exclusive,
have been suggested to explain this phenomenon: the
proliferation of existing melanocytes, differentiation of
melanocyte precursor cells (melanoblasts) to mature melano-
cytes, and activation of melanin synthesis in dormant mature
melanocytes, causing them to become detectable (Gilchrest
et al., 1979; Rosen et al., 1987; An et al., 2001; Hachiya
et al., 2001).
We and others have previously shown that primary cell
cultures and several cultured cell lines enter a dose-
dependent transient cell cycle arrest after UV exposure (Eller
et al., 1997; Lo et al., 2005). In this study, Ki67 staining
indicates that pTT and UV both reduce epidermal prolifera-
tion rates for at least 24 hours. The number of Ki67 (þ ) cells
then increases 2- to 3-fold, B50–70% above basal levels, by
48 through 120 hours, consistent with the known UV-
induced hyperproliferation of epidermal cells (Lee et al.,
2002). Of note, although this rebound hyperproliferation is
implicated in fixing mutations after UV exposure and
promoting development of skin cancer including melanoma
(Gilchrest et al., 1999), this would not be the case following
pTT treatment that does not introduce photoproducts or other
detectible damage into DNA. Melanocytes, in contrast to
keratinocytes, have a very low constitutive mitotic activity
(McGill et al., 2002; Stefanato et al., 2003). In this study, pTT
and UV irradiation slightly but not significantly increased this
low proliferative rate, as shown by double Tyr/Ki67 (þ ) cells,
with highest rates of approximately 0.5 cells/100 mm at
120 hours after treatment (Figure 2a and d), equivalent to
approximately 1 in 10 of the detectable melanocytes. Hence,
increase in the number of detectable melanocytes could not
be attributed to melanocyte proliferation, as they first
appeared during a period of epidermal growth arrest when
no proliferation (Ki67þmelanocytes) could be detected.
Furthermore, expression of melanogenic proteins continued
to increase moderately over several days despite minimal
detectable melanocyte proliferation.
The tumor suppressor p53, termed ‘‘guardian of the
genome’’ for its central role in safeguarding DNA integrity
(Lane, 1992), transcriptionally upregulates several DNA
repair genes including xeroderma pigmentosum group C
(XPC), growth arrest and DNA damage 45 (GADD45),
excision repair cross-complementing 1 (ERCC1)/xeroderma
pigmentosum group F (XPF), and proliferating-cell nuclear
antigen (PCNA) (Shivakumar et al., 1995; Ford and Hanawalt,
1997; Smith and Fornace, 1997). p53 also arrests the cell
cycle, allowing more time for DNA repair (Petrocelli et al.,
1996). Both UVB irradiation and pTT treatment upregulate
and activate p53 within 24 hours (Eller et al., 1997;
Davenport et al., 1999; Goukassian et al., 2002; Marwaha
et al., 2005), including in human skin explants (Arad et al.,
2006). Consistent with this, in this study, within 72 hours
DNA repair rate following a moderately damaging UV dose
was greatly accelerated in explants pretreated with pTT or
preirradiated. The possibility that the higher CPD burden in
the diluent-pretreated then pTT- or UV-pretanned explants at
time 0 (approximately 28 vs 14–15 CPD (þ ) nuclei per
100mm epidermal length) might have overwhelmed the
cellular DNA repair capacity, falsely suggesting accelerated
repair in the other groups, seems very unlikely. First, rate of
repair (percent reduction in CPD (þ ) nuclei over 72 hours)
was identical as measured in pTT-pretreated explants with no
CPDs at the time of the 2nd UVB (Figure 3a, middle image)
and in UV-pretreated explants that still contained many CPD
(þ ) nuclei (Figure 3a, image on the right). Second, Tadokoro
et al. (2003), using a very similar methodology to compare
UV-induced DNA damage in volunteers with a 410-fold
range of constitutive epidermal pigmentation, found very
similar rates of CPD removal in most subjects over both
24 hours and 7 day intervals, despite an often 42-fold
difference in initial CPD burden. Indeed, subjects with the
highest initial CPD burden often had the most rapid rates of
CPD removal. As well, using cultured human fibroblasts, we
have previously published comparable acceleration of
UV-induced CPD removal following pTT versus diluent pre-
treatment using an experimental design in which all cultures
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had the same initial CPD burden (Goukassian et al., 2002),
comparable to that in this study. Moreover, our laboratory
has shown that topical application of pTT decreased mutation
frequency and reduced photocarcinogenesis in both wild-
type and partially repair-deficient Xpcþ / hairless LacZ
mutation-indicator transgenic mice (Goukassian et al., 2004)
through enhanced DNA repair capacity. In these mice
lacking epidermal melanin, additional photoprotection ob-
tainable from pTT-induced tanning could not be observed.
Additionally, in our present studies a further degree of
protection may have been afforded by the fact that CPD (þ )
cells generated after the 2nd UVB irradiation were limited to
the upper layers of epidermis, consistent with protective
pigmentation in basal and immediately suprabasal layers
induced in melanocytes by pTT or a first UVB exposure and
transferred to keratinocytes via the also induced melanocyte
dendrites. This phenomenon may preferentially protect
proliferating cells and presumptive stem cells in this
compartment against subsequent UV damage (Yamaguchi
et al., 2006).
Our data thus confirm in human skin the existence of
inducible SOS-like responses, also termed ‘‘photoadaptive
responses’’ (Agar and Young, 2005), previously documented
in human skin cells in vitro (Eller et al., 1997; Goukassian
et al., 2002) and in mouse skin in vivo (Goukassian et al.,
2004). These responses are comparably induced within 3
days by a moderately damaging UV exposure or by a single
exposure to pTT but in the latter instance without initial DNA
damage. We therefore propose that pTT treatment may
provide a novel approach to reducing photodamage, includ-
ing photocarcinogenesis.
MATERIALS AND METHODS
Skin explants
Otherwise discarded normal skin from Caucasian donors was placed
in sterile medium and brought to the laboratory within minutes after
removal during surgery. The studies performed in this paper are in
full compliance with the Declaration of Helsinki Principles. Patient
consent for experiments was not required because institutional
approval considers human tissue left over from surgery as discarded
material. Subcutaneous fat was dissected away and each skin
specimen was cut into multiple pieces (approximately 5 5 mm) and
placed in groups of 3–5 in 60 mm dishes (Falcon, Becton Dickinson
Labware, Franklin Lakes, NJ). Explants were maintained in 50:50
mixture of DMEM (Mediatech Inc., Herndon, VA) with 10% calf
serum plus KBM-2 (keratinocyte basal medium-2) with epidermal
growth factor as described before (Arad et al., 2006).
Experimental protocol and UVB irradiation
To determine the effect of pTT or UV on melanogenesis, 24 hours
after establishment in culture, explants in paired dishes were either
provided media supplemented with pTT or diluent alone and a third
was UV irradiated with 30 mJ/cm2 UVB. Explants from each
condition were then harvested at 24 hours intervals. For UVB
irradiation, skin explants were placed in phosphate-buffered saline
and irradiated through the plastic culture dish cover by using a solar
simulator (Spectral Energy Corp., Westwood, NJ). The 1 kW xenon
arc lamp was used (XMN-1000-21; Optical Radiation Corp., Azuza,
CA). Irradiance was adjusted to 5 105 W/cm2, and dishes were
exposed to 30 mJ/cm2 as measured with a research radiometer fitted
with a UV light probe at 28575 nm (model IL1700 A; International
Light, Newburyport, MA) (Marwaha et al., 2005). This protocol
exposes cells to a moderately damaging UV dose, roughly equivalent
to a 3-minimal erythemal dose (3-MED) dose, and a spectrum of
light closely resembling terrestrial sunlight (Werninghaus et al.,
1991). After irradiation, cells were given fresh medium lacking pTT.
To examine the protective effect of pTT on subsequent DNA
damage, after a 72-hour incubation one explant from each condition
was harvested and then all remaining explants were irradiated with
equal dose (30 mJ/cm2) of UVB for a second time and harvested
immediately or after 72 hours. Skin explants were kept in a 371C
incubator with 5% carbon dioxide. After harvesting, they were fixed
in optimal cutting temperature (OCT) compound and stored at
801C until processing.
Oligonucleotides
pTT was purchased from the Midland Reagent Company (Midland
Certified, TX), reconstituted as a 2 mM stock, and diluted with culture
medium to a final 100mM concentration for use in skin experiments.
Skin explants were provided pTT or diluent alone once at time 0 and
harvested at intervals.
Immunostaining
Multiple 6 mm frozen sections were cut and placed on glass slides.
Slides were fixed with 4% formaldehyde and ethyl alcohol. After
blocking with normal goat serum, they were incubated with a mouse
monoclonal Tyr antibody (Vector Laboratories, Burlingame, CA).
The next day after washing with Tris-buffered saline (TBS) they were
incubated with secondary FITC-labeled goat anti-mouse (Jackson
ImmunoResearch, Westgrove, PA). Then mouse monoclonal anti-
bodies against Mel5 (TRP-1) (Signet Laboratories, Dedham, MA) and
Ki67 (Dako Citomation, Carpinteria, CA) were used. A tetramethyl
rhodamine isothiocyanate-labeled goat anti-mouse secondary anti-
body (Jackson ImmunoResearch, Westgrove, PA) was used.
For CPD staining, we used a minor modification of the antibody
manufacturer’s protocol. Briefly, 6 mm sections were fixed in acetone
for 10 minutes at 201C and then were dried at room temperature.
Slides were then immersed in boiling citrate buffer (pH¼ 6) for
5 minutes. After washing with 1 TBS three times, DNA was
neutralized by incubating slides in 70% ethanol/sodium hydroxide
(NaOH) for 15 minutes. After washing with 1 TBS, sections were
incubated with 100 mg/ml of RNAase A solution for 30 minutes at
371C, then washed three times with 1 TBS, and incubated with
20% fetal bovine serum for 30 minutes at 371C. Sections then were
incubated with anti-CPD antibodies (1/100 dilution, Medical and
Biological Laboratories, Naka-ku, Nagoya, Japan) in 5% fetal bovine
serum at 41C overnight. Next morning after washing with 1 TBS,
they were incubated with FITC-labeled secondary goat anti-mouse
antibodies (Jackson ImmunoResearch, West Grove, PA) for 45 min-
utes at 371C. After washing with 1 TBS three times, slides were
cover slipped using Vectashield mounting medium with 40,6-
diamidino-2-phenylindole (DAPI) (Vector Laboratories), viewed at
 400 magnification using a multicolor fluorescence microscope
(Nikon, Nikon Instruments Inc., Melville, NY), and analyzed using a
digital image analysis system (Nikon). Representative images are
shown in Figure S4. CPD burden was expressed as the ratio of
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staining intensity for CPD-stained sections to DAPI-stained sections,
after conversion of the images to black and white pixels (Figure S4),
using computer-assisted NIH ImageJ program. CPD burden was also
calculated using CPD staining intensity alone and this method gave
essentially identical results (data not shown in this paper).
Statistical analysis
Analysis of variance by Fisher protected least significant difference
and unpaired t-test (StatView statistical program SAS Institute, Gary,
NC) was used to detect the differences in the number of positive cells
among treatment conditions. Differences were considered significant
when Po0.05.
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Figure S1. Tyr and Mel5 immunostaining of human skin explants at 24 hours.
Figure S2. Double immunostaining for Tyr and Ki67.
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Figure S4. Computer-assisted image analysis of CPD staining.
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